Validation of green tea polyphenol biomarkers in a phase II human intervention trial.

PubWeight™: 0.96‹?› | Rank: Top 15%

🔗 View Article (PMC 2253676)

Published in Food Chem Toxicol on August 17, 2007

Authors

Jia-Sheng Wang1, Haitao Luo, Piwen Wang, Lili Tang, Jiahua Yu, Tianren Huang, Stephen Cox, Weimin Gao

Author Affiliations

1: Department of Environmental Toxicology, The Institute of Environmental and Human Health, Texas Tech University, Box 41163, Lubbock, TX 79409-1163, USA. js.wang@ttu.edu

Articles citing this

Protective effect of green tea polyphenols on bone loss in middle-aged female rats. Osteoporos Int (2007) 1.20

Green tea and bone metabolism. Nutr Res (2009) 1.12

Green tea polyphenols and metabolites in prostatectomy tissue: implications for cancer prevention. Cancer Prev Res (Phila) (2010) 1.12

Nongallated compared with gallated flavan-3-ols in green and black tea are more bioavailable. J Nutr (2008) 1.08

Green tea and bone health: Evidence from laboratory studies. Pharmacol Res (2011) 0.95

Pharmacokinetic and chemoprevention studies on tea in humans. Pharmacol Res (2011) 0.93

Green tea polyphenols attenuate deterioration of bone microarchitecture in female rats with systemic chronic inflammation. Osteoporos Int (2010) 0.92

Synergistic effects of green tea polyphenols and alphacalcidol on chronic inflammation-induced bone loss in female rats. Osteoporos Int (2010) 0.87

High-dose green tea polyphenols induce nephrotoxicity in dextran sulfate sodium-induced colitis mice by down-regulation of antioxidant enzymes and heat-shock protein expressions. Cell Stress Chaperones (2011) 0.86

Green tea polyphenols and Tai Chi for bone health: designing a placebo-controlled randomized trial. BMC Musculoskelet Disord (2009) 0.85

Bioactive food components and cancer-specific metabonomic profiles. J Biomed Biotechnol (2010) 0.84

Epigenetic dysregulation in Epstein-Barr virus-associated gastric carcinoma: disease and treatments. World J Gastroenterol (2014) 0.84

Mitigation of oxidative damage by green tea polyphenols and Tai Chi exercise in postmenopausal women with osteopenia. PLoS One (2012) 0.81

Biomarkers of Dietary Polyphenols in Cancer Studies: Current Evidence and Beyond. Oxid Med Cell Longev (2015) 0.79

Green tea polyphenols avert chronic inflammation-induced myocardial fibrosis of female rats. Inflamm Res (2011) 0.78

Molecular structure-function relationship of dietary polyphenols for inhibiting VEGF-induced VEGFR-2 activity. Mol Nutr Food Res (2015) 0.76

Therapeutic properties of green tea against environmental insults. J Nutr Biochem (2016) 0.75

Articles cited by this

Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit Rev Food Sci Nutr (2003) 3.75

Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer Res (2006) 3.39

Inhibition of carcinogenesis by tea. Annu Rev Pharmacol Toxicol (2002) 2.80

Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. Cancer Epidemiol Biomarkers Prev (2002) 2.29

Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E. Cancer Epidemiol Biomarkers Prev (2001) 1.87

Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. Cancer Epidemiol Biomarkers Prev (1998) 1.87

Enzymology of methylation of tea catechins and inhibition of catechol-O-methyltransferase by (-)-epigallocatechin gallate. Drug Metab Dispos (2003) 1.74

Analysis of plasma and urinary tea polyphenols in human subjects. Cancer Epidemiol Biomarkers Prev (1995) 1.70

Green tea, black tea and breast cancer risk: a meta-analysis of epidemiological studies. Carcinogenesis (2005) 1.66

Green tea polyphenols and cancer: biologic mechanisms and practical implications. Nutr Rev (1999) 1.51

Cancer chemopreventive activity and bioavailability of tea and tea polyphenols. Mutat Res (2003) 1.50

Safety studies on epigallocatechin gallate (EGCG) preparations. Part 2: dermal, acute and short-term toxicity studies. Food Chem Toxicol (2006) 1.48

Stability of tea polyphenol (-)-epigallocatechin-3-gallate and formation of dimers and epimers under common experimental conditions. J Agric Food Chem (2005) 1.36

Green tea, black tea and colorectal cancer risk: a meta-analysis of epidemiologic studies. Carcinogenesis (2006) 1.34

Glucuronides of tea catechins: enzymology of biosynthesis and biological activities. Drug Metab Dispos (2003) 1.32

Metabolism of green tea catechins: an overview. Curr Drug Metab (2006) 1.32

Structural identification of two metabolites of catechins and their kinetics in human urine and blood after tea ingestion. Chem Res Toxicol (2000) 1.28

An improved method for the determination of green and black tea polyphenols in biomatrices by high-performance liquid chromatography with coulometric array detection. Anal Biochem (2000) 1.26

Inhibition of activator protein 1 activity and cell growth by purified green tea and black tea polyphenols in H-ras-transformed cells: structure-activity relationship and mechanisms involved. Cancer Res (1999) 1.22

Urinary tea polyphenols in relation to gastric and esophageal cancers: a prospective study of men in Shanghai, China. Carcinogenesis (2002) 1.22

Urinary biomarkers of tea polyphenols and risk of colorectal cancer in the Shanghai Cohort Study. Int J Cancer (2007) 1.20

Identification and characterization of methylated and ring-fission metabolites of tea catechins formed in humans, mice, and rats. Chem Res Toxicol (2002) 1.18

Molecular targets for the cancer preventive activity of tea polyphenols. Mol Carcinog (2006) 1.17

Phase IIa chemoprevention trial of green tea polyphenols in high-risk individuals of liver cancer: modulation of urinary excretion of green tea polyphenols and 8-hydroxydeoxyguanosine. Carcinogenesis (2005) 1.16

Safety studies on epigallocatechin gallate (EGCG) preparations. Part 1: genotoxicity. Food Chem Toxicol (2005) 1.12

Glucuronidation and sulfation of the tea flavonoid (-)-epicatechin by the human and rat enzymes. Drug Metab Dispos (2002) 1.10

Enhancement of antioxidant and phase II enzymes by oral feeding of green tea polyphenols in drinking water to SKH-1 hairless mice: possible role in cancer chemoprevention. Cancer Res (1992) 1.09

Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced NF-kappaB activation by tea polyphenols, (-)-epigallocatechin gallate and theaflavins. Carcinogenesis (2000) 1.08

Synthesis and structure identification of thiol conjugates of (-)-epigallocatechin gallate and their urinary levels in mice. Chem Res Toxicol (2005) 1.08

Safety studies on epigallocatechin gallate (EGCG) preparations. Part 3: teratogenicity and reproductive toxicity studies in rats. Food Chem Toxicol (2006) 1.00

Analysis of urinary metabolites of tea catechins by liquid chromatography/electrospray ionization mass spectrometry. Chem Res Toxicol (2001) 0.99

Genetic and environmental risk factors for Parkinson's disease in a Chinese population. J Neurol Neurosurg Psychiatry (1998) 0.99

Tea flavonols in cardiovascular disease and cancer epidemiology. Proc Soc Exp Biol Med (1999) 0.93

Formation and identification of 4'-O-methyl-(-)-epigallocatechin in humans. Drug Metab Dispos (2001) 0.88

Tea polyphenols in preventing cardiovascular diseases. Cardiovasc Res (2006) 0.83

Specific induction of glutathione S-transferase GSTM2 subunit expression by epigallocatechin gallate in rat liver. Biochem Pharmacol (2000) 0.82

Free radical scavenging by green tea polyphenols. Methods Enzymol (2001) 0.82

Articles by these authors

NONCODE v3.0: integrative annotation of long noncoding RNAs. Nucleic Acids Res (2011) 2.82

Large-scale prediction of long non-coding RNA functions in a coding-non-coding gene co-expression network. Nucleic Acids Res (2011) 2.55

Utilizing sequence intrinsic composition to classify protein-coding and long non-coding transcripts. Nucleic Acids Res (2013) 1.64

Translating the therapeutic potential of AZD4547 in FGFR1-amplified non-small cell lung cancer through the use of patient-derived tumor xenograft models. Clin Cancer Res (2012) 1.53

FGFR2 gene amplification in gastric cancer predicts sensitivity to the selective FGFR inhibitor AZD4547. Clin Cancer Res (2013) 1.51

Randomized clinical trial of brewed green and black tea in men with prostate cancer prior to prostatectomy. Prostate (2014) 1.47

Long non-coding RNAs function annotation: a global prediction method based on bi-colored networks. Nucleic Acids Res (2012) 1.46

ncFANs: a web server for functional annotation of long non-coding RNAs. Nucleic Acids Res (2011) 1.46

Determinants of aflatoxin levels in Ghanaians: sociodemographic factors, knowledge of aflatoxin and food handling and consumption practices. Int J Hyg Environ Health (2006) 1.34

Linking microbial community structure and function to seasonal differences in soil moisture and temperature in a Chihuahuan desert grassland. Microb Ecol (2009) 1.32

Transcriptome analysis of Shewanella oneidensis MR-1 in response to elevated salt conditions. J Bacteriol (2005) 1.31

Analysis of tumor-host interactions by gene expression profiling of lung adenocarcinoma xenografts identifies genes involved in tumor formation. Mol Cancer Res (2005) 1.27

Soil microbial responses to temporal variations of moisture and temperature in a chihuahuan desert grassland. Microb Ecol (2008) 1.22

Etiological study of esophageal squamous cell carcinoma in an endemic region: a population-based case control study in Huaian, China. BMC Cancer (2006) 1.18

Phase IIa chemoprevention trial of green tea polyphenols in high-risk individuals of liver cancer: modulation of urinary excretion of green tea polyphenols and 8-hydroxydeoxyguanosine. Carcinogenesis (2005) 1.16

Modulation of aflatoxin biomarkers in human blood and urine by green tea polyphenols intervention. Carcinogenesis (2008) 1.15

Bronchogenic cysts in retroperitoneal region. Abdom Imaging (2013) 1.12

A novel aptamer developed for breast cancer cell internalization. ChemMedChem (2011) 1.10

Fumonisin B1 contamination of home-grown corn in high-risk areas for esophageal and liver cancer in China. Food Addit Contam (2007) 1.08

p53-Dependent anticancer effects of leptomycin B on lung adenocarcinoma. Cancer Chemother Pharmacol (2010) 1.06

Expression of wild soybean WRKY20 in Arabidopsis enhances drought tolerance and regulates ABA signalling. J Exp Bot (2013) 1.06

Chemopreventive effects of tea in prostate cancer: green tea versus black tea. Mol Nutr Food Res (2011) 1.06

Efficient activation of aflatoxin B1 by cytochrome P450 2A13, an enzyme predominantly expressed in human respiratory tract. Int J Cancer (2006) 1.05

Influence of Matrices on Oxygen Sensing of Three Sensing Films with Chemically Conjugated Platinum Porphyrin Probes and Preliminary Application for Monitoring of Oxygen Consumption of Escherichia coli (E. coli). Sens Actuators B Chem (2010) 1.04

Inhibition of cholinergic signaling causes apoptosis in human bronchioalveolar carcinoma. Cancer Res (2012) 1.02

Capsaicin displays anti-proliferative activity against human small cell lung cancer in cell culture and nude mice models via the E2F pathway. PLoS One (2010) 0.99

Nicotine induces the up-regulation of the α7-nicotinic receptor (α7-nAChR) in human squamous cell lung cancer cells via the Sp1/GATA protein pathway. J Biol Chem (2013) 0.98

The nature of caregiving in children of a parent with multiple sclerosis from multiple sources and the associations between caregiving activities and youth adjustment overtime. Psychol Health (2011) 0.96

Effect of Angelica gigas extract on melanogenesis in B16 melanoma cells. Int J Mol Med (2007) 0.96

Genetic variations of hepatitis B virus and serum aflatoxin-lysine adduct on high risk of hepatocellular carcinoma in Southern Guangxi, China. J Hepatol (2010) 0.94

Chronic toxicological evaluation of dietary NovaSil clay in Sprague-Dawley rats. Food Addit Contam (2005) 0.94

Metal reduction and iron biomineralization by a psychrotolerant Fe(III)-reducing bacterium, Shewanella sp. strain PV-4. Appl Environ Microbiol (2006) 0.92

Quantitative single-cell gene expression measurements of multiple genes in response to hypoxia treatment. Anal Bioanal Chem (2011) 0.92

Polyphenols in brewed green tea inhibit prostate tumor xenograft growth by localizing to the tumor and decreasing oxidative stress and angiogenesis. J Nutr Biochem (2012) 0.92

MG624, an α7-nAChR antagonist, inhibits angiogenesis via the Egr-1/FGF2 pathway. Angiogenesis (2011) 0.92

Airway inflammatory markers in individuals with cystic fibrosis and non-cystic fibrosis bronchiectasis. J Inflamm Res (2013) 0.91

Pecans acutely increase plasma postprandial antioxidant capacity and catechins and decrease LDL oxidation in humans. J Nutr (2010) 0.91

Perchlorate in wet deposition across North America. Environ Sci Technol (2009) 0.90

A dual sensor for real-time monitoring of glucose and oxygen. Biomaterials (2013) 0.90

Inhibitory effect of baicalin and baicalein on ovarian cancer cells. Int J Mol Sci (2013) 0.88

The protective effects of green tea polyphenols: lipid profile, inflammation, and antioxidant capacity in rats fed an atherogenic diet and dextran sodium sulfate. J Med Food (2012) 0.88

Promoter methylation of RASSF1A and DAPK and mutations of K-ras, p53, and EGFR in lung tumors from smokers and never-smokers. BMC Cancer (2007) 0.88

Are roadside pedestrian injury patterns predictable in a densely populated, urban setting? J Surg Res (2010) 0.88

DNA demethylation by 5-aza-2-deoxycytidine treatment abrogates 17 beta-estradiol-induced cell growth and restores expression of DNA repair genes in human breast cancer cells. Cancer Lett (2011) 0.88

Aflatoxin B1 modulates the expression of phenotypic markers and cytokines by splenic lymphocytes of male F344 rats. J Appl Toxicol (2013) 0.88

Interaction between IGF-IR and ER induced by E2 and IGF-I. PLoS One (2013) 0.87

Epigenetic effects of green tea polyphenols in cancer. Epigenomics (2013) 0.87

Optimization of whole-transcriptome amplification from low cell density deep-sea microbial samples for metatranscriptomic analysis. J Microbiol Methods (2010) 0.87

Phenolic acid concentrations in plasma and urine from men consuming green or black tea and potential chemopreventive properties for colon cancer. Mol Nutr Food Res (2013) 0.85

Anticancer activities of (-)-epigallocatechin-3-gallate encapsulated nanoliposomes in MCF7 breast cancer cells. J Liposome Res (2013) 0.85

Monitoring the single-cell stress response of the diatom Thalassiosira pseudonana by quantitative real-time reverse transcription-PCR. Appl Environ Microbiol (2013) 0.85

Chemotherapeutic sensitization of leptomycin B resistant lung cancer cells by pretreatment with doxorubicin. PLoS One (2012) 0.85

Targeted delivery of 5-fluorouracil to HT-29 cells using high efficient folic acid-conjugated nanoparticles. Drug Deliv (2014) 0.84

Leptin reduces plasma ANP level via nitric oxide-dependent mechanism. Am J Physiol Regul Integr Comp Physiol (2010) 0.84

Testing a model of physical activity among mothers and fathers of young children: integrating self-determined motivation, planning, and the theory of planned behavior. J Sport Exerc Psychol (2012) 0.84

Computational methods to predict long noncoding RNA functions based on co-expression network. Methods Mol Biol (2014) 0.84

Green tea polyphenols reduce body weight in rats by modulating obesity-related genes. PLoS One (2012) 0.83

Systematic study of human long intergenic non-coding RNAs and their impact on cancer. Sci China Life Sci (2013) 0.83

The dimensional structure of benefit finding in multiple sclerosis and relations with positive and negative adjustment: A longitudinal study. Psychol Health (2009) 0.83

Induction of G1 arrest and apoptosis by Scutellaria barbata in the human promyelocytic leukemia HL-60 cell line. Int J Mol Med (2007) 0.83

Validation of fumonisin biomarkers in F344 rats. Toxicol Appl Pharmacol (2007) 0.83

Methylation profiling of 48 candidate genes in tumor and matched normal tissues from breast cancer patients. Breast Cancer Res Treat (2015) 0.83

Antioxidant capacity and phytochemical content of herbs and spices in dry, fresh and blended herb paste form. Int J Food Sci Nutr (2010) 0.82

Reversal of multidrug resistance by gefitinib via RAF1/ERK pathway in pancreatic cancer cell line. Anat Rec (Hoboken) (2012) 0.82

4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone [corrected] induces CRM1-dependent p53 nuclear accumulation in human bronchial epithelial cells. Toxicol Sci (2010) 0.82

Whole genome gene copy number profiling of gastric cancer identifies PAK1 and KRAS gene amplification as therapy targets. Genes Chromosomes Cancer (2014) 0.82

Test of a model of the effects of parental illness on youth and family functioning. Health Psychol (2011) 0.82

Comparative acute and combinative toxicity of aflatoxin B1 and T-2 toxin in animals and immortalized human cell lines. J Appl Toxicol (2006) 0.82

Effect of early orthodontic force on periodontal healing after autotransplantation of permanent incisors in beagle dogs. J Periodontol (2011) 0.82

Distinct outcomes in patients with different molecular subtypes of inflammatory breast cancer. Saudi Med J (2014) 0.81

Triazacryptand-based fluorescent sensors for extracellular and intracellular K+ sensing. Biomaterials (2011) 0.81

PAH exposure in a Ghanaian population at high risk for aflatoxicosis. Sci Total Environ (2009) 0.81

What factors are predictive of benefit finding in women treated for non-metastatic breast cancer? A prospective study. Psychooncology (2014) 0.81

Green tea polyphenols benefits body composition and improves bone quality in long-term high-fat diet-induced obese rats. Nutr Res (2012) 0.81

Physiologically based toxicokinetics of serum aflatoxin B1-lysine adduct in F344 rats. Toxicology (2012) 0.81

Mitigation of oxidative damage by green tea polyphenols and Tai Chi exercise in postmenopausal women with osteopenia. PLoS One (2012) 0.81

Antibody microarray analysis of serum glycans in esophageal squamous cell carcinoma cases and controls. Proteomics Clin Appl (2009) 0.81

Integrated metagenomic and metatranscriptomic analyses of microbial communities in the meso- and bathypelagic realm of north pacific ocean. Mar Drugs (2013) 0.81

CRM1-dependent p53 nuclear accumulation in lung lesions of a bitransgenic mouse lung tumor model. Oncol Rep (2011) 0.80

A gel-based proteomic analysis of the effects of green tea polyphenols on ovariectomized rats. Nutrition (2010) 0.79

Parallel RNA extraction using magnetic beads and a droplet array. Lab Chip (2015) 0.78

Curcumin modulates eukaryotic initiation factors in human lung adenocarcinoma epithelial cells. Mol Biol Rep (2009) 0.78

Periodontal disease and spontaneous preterm birth: a case control study. BMC Pregnancy Childbirth (2006) 0.78

Use of compound Chinese medicine in the treatment of lung cancer. Curr Drug Discov Technol (2010) 0.78

Toxic response indicators of microcystin-LR in F344 rats following a single-dose treatment. Toxicon (2008) 0.78

An assessment of late fixed functional treatment and the stability of Forsus appliance effects. Aust Orthod J (2014) 0.78

Development of the benefit finding in multiple sclerosis (MS) caregiving scale: a longitudinal study of relations between benefit finding and adjustment. Br J Health Psychol (2008) 0.78

Mast cell-based electrochemical biosensor for quantification of the major shrimp allergen Pen a 1 (tropomyosin). Biosens Bioelectron (2013) 0.78

[Psychometric features of the body image after breast cancer questionnaire-Chinese version in women with breast cancer]. Zhong Nan Da Xue Xue Bao Yi Xue Ban (2014) 0.77

The role of viruses in the clinical presentation of chronic rhinosinusitis. Am J Rhinol Allergy (2015) 0.77